Monitoring Advanced NSCLC through plasma Genotyping during Immunotherapy: Clinical feasibility and application (MAGIC-2)

Monitoring Advanced NSCLC through plasma Genotyping during Immunotherapy: Clinical feasibility and application (MAGIC-2)

Stato

aperto

Copertura

Nazionale

Tipologia

Ricerca di base/clinica

Ruolo di capofila/partner

Capofila

Ente finanziatore

IOV - IRCCS

Principal Investigator

Prof. Stefano Indraccolo

Anno di finanziamento

2018
Scroll to Top